We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AbbVie and C2N Enter into a Worldwide License Agreement

News   Mar 27, 2015

 
AbbVie and C2N Enter into a Worldwide License Agreement
 
 
 

RELATED ARTICLES

Fire, Sun or Electricity Powers Hand-held Cancer Detection Device

News

Device shows promise as a point-of-care detector of Kaposi sarcoma-associated herpesvirus in resource-limited settings.

READ MORE

Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players

News

Genetic data highlights the previously understated role CD4+ T cells and MHC-II molecules play in keeping cancer at bay.

READ MORE

Protein Curbs Obesity Through Our Gut Bacteria

News

Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE